Wheatley, Keith

Mortality in relation to smoking: 40 years' observations on male British doctors

Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ

Smoking Behavior and CessationGlobal Cancer Incidence and Screening

Cited by 5,932

Association between premature mortality and hypopituitarism

Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet

Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth Factors

Cited by 1,006

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Kumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., et al. (2012) · Leukemia

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 721

A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment

Burnett, A. K., Milligan, D., Prentice, A. G., Goldstone, A. H., McMullin, M. F., Hills, R. K., & Wheatley, K. (2007) · Cancer

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 619

Bortezomib for the treatment of multiple myeloma

Scott, K., Hayden, P. J., Will, A., Wheatley, K., & Coyne, I. (2016) · Cochrane Database of Systematic Reviews

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 158

Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial

Milligan, D. W., Wheatley, K., Littlewood, T., Craig, J. I. O., Burnett, A. K., & for the NCRI Haematological Oncology Clinical Studies Group (2006) · Blood

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 141

Bisphosphonates in multiple myeloma: a network meta-analysis

Mhaskar, R., Redzepovic, J., Wheatley, K., Clark, O. A. C., Miladinovic, B., Glasmacher, A., Kumar, A., & Djulbegovic, B. (2012) · Cochrane Database of Systematic Reviews

Bone health and treatmentsMultiple Myeloma Research and Treatments

Cited by 130

Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)

Clarke, C. E., Patel, S., Ives, N., Rick, C. E., Woolley, R., Wheatley, K., Walker, M. F., Zhu, S., Kandiyali, R., Yao, G., et al. (2016) · Health Technology Assessment

Parkinson's Disease Mechanisms and TreatmentsOccupational Therapy Practice and Research

Cited by 110

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

Craddock, C. F., Houlton, A. E., Quek, L. S., Ferguson, P., Gbandi, E., Roberts, C., Metzner, M., Garcia-Martin, N., Kennedy, A., Hamblin, A., et al. (2017) · Clinical Cancer Research

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 88

Phase III assessment of topotecan and cyclophosphamide and high-dose ifosfamide in rEECur: An international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).

McCabe, M., Kirton, L., Khan, M., Fenwick, N., Strauss, S. J., Valverde, C., Mata, C., Gaspar, N., Luksch, R., Longhi, A., et al. (2022) · Journal of Clinical Oncology

Sarcoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research

Cited by 46